Alibaba raised $21.8 billion in its IPO on Friday, making it the world's largest IPO ever. At $94, Alibaba commands a diluted market value of $242 billion; it is now the 10th-largest US-listed company, just behind Walmart. With one deal, the total capital raised...read more
The week of Alibaba's $22 billion IPO kicked off with a broken LBO and a high flying biotech. Prostate cancer biotech Tokai Pharmaceuticals (TKAI) closed 58% above its offer price by the end of Wednesday, while Civitas Solutions (CIVI) broke issue. This...read more
Tokai Pharmaceuticals, a biotech developing small molecule therapies for prostate cancer, raised $97 million in an upsized IPO by offering 6.5 million shares at $15, the high end of the range of $13 to $15. The company originally filed to offer 5.4 million...read more
US IPO Pricing Recap: Alibaba pops 38%, represents one third of 2014 IPO market proceeds
Alibaba raised $21.8 billion in its IPO on Friday, making it the world's largest IPO ever. At $94, Alibaba commands a diluted market value of $242 billion; it is now the 10th-largest US-listed company, just behind Walmart. With one deal, the total capital raised...read more
Civitas falls below IPO price and Tokai Pharmaceuticals soars
The week of Alibaba's $22 billion IPO kicked off with a broken LBO and a high flying biotech. Prostate cancer biotech Tokai Pharmaceuticals (TKAI) closed 58% above its offer price by the end of Wednesday, while Civitas Solutions (CIVI) broke issue. This...read more
Tokai Pharmaceuticals prices upsized IPO at $15, the high end of the range
Tokai Pharmaceuticals, a biotech developing small molecule therapies for prostate cancer, raised $97 million in an upsized IPO by offering 6.5 million shares at $15, the high end of the range of $13 to $15. The company originally filed to offer 5.4 million...read more
Alibaba and 6 health care IPOs planned for the week of September 15
The IPO market has returned in full force, beginning with the 117% first-day pop of ReWalk Robotics...read more